Diagnostics Market in Transition--Amid Regulatory Uncertainty and Intensifying Competition

NEW YORK - July 14, 2014 - PRLog -- Venture Planning Group (www.vpgmarketresearch.com), an international publishing and management consulting firm, is pleased to introduce “Diagnostics Market in Transition--Amid Regulatory Uncertainty and Intensifying Competition,” a series of new global surveys designed to identify major business opportunities emerging in the diagnostics market during the next five years.  The reports examine key trends in the U.S., five major European countries (France, Germany, Italy, Japan, UK) and Japan; review over 400 current and emerging assays; analyze potential applications of innovative diagnostic technologies; forecast volume and sales by assay, market segment, and country; provide test volume estimates by method; profile leading players and potential market entrants; and suggest alternative business expansion strategies for suppliers.

To review these new reports, please visit http://www.vpgmarketresearch.com/Diagnostics-Market-in-Transition.html

- WINNING STRATEGIES IN MOLECULAR DIAGNOSTICS
Integrating New Technology Planning with Business and Corporate Strategies
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

- INFECTIOUS DISEASE TESTING: RAPIDLY GROWING AND CHALLENGING MARKET FACING SUPPLIERS
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

- CANCER DIAGNOSTICS: MARKET ON THE VERGE OF EXPLOSION
Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

- IMMUNODIAGNOSTICS: SPOT FAST-GROWING MARKET SEGMENTS
Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

- HEMATOLOGY AND FLOW CYTOMETRY: A MARKET FACING REGULATORY AND COMPETITIVE CHALLENGES
Advances in Molecular Diagnostics, IT, and Growing Understanding of Immunologic Forces Regulating Systemic Diseases Will Profoundly Impact the Market

- COAGULATION TESTING IN TRANSITION
Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside

- 2014 MOLECULAR BLOOD TYPING, GROUPING AND INFECTIOUS DISEASE NAT MARKET
France, Germany, Italy, Japan, Spain, UK, US--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

These thought-provoking reports are designed to provide the in vitro diagnostics industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs.

The studies offer expert analyses, strategic insights and granular data, such as supplier shares and sales forecasts for over 400 diagnostic tests by country and market segment.

The reports are available by region, country, section, market segment, individual test, and can be custom-tailored to specific information needs and budget.

The global diagnostic market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances will radically change the global diagnostics market during the next five years.  New specific and sensitive markers will be increasingly used on automated instrumentation.  Diagnostic testing will also become more standardized, offering opportunities for quality control products and services.  Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the diagnostic testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

To review these and related IVD reports, please visit http://www.vpgmarketresearch.com/In-Vitro-Diagnostics

For further details or questions regarding these reports, please contact:

Robert Fisher

Robert@vpgcorp.com

+1 212 564 2838

http://www.VPGMarketResearch.com

www.LeadingMarketResearch.com